Avinger (NASDAQ:AVGR – Get Free Report) is expected to announce its earnings results before the market opens on Wednesday, March 19th. Analysts expect the company to announce earnings of ($0.40) per share and revenue of $1.86 million for the quarter.
Avinger Price Performance
NASDAQ:AVGR opened at $0.47 on Monday. Avinger has a 12-month low of $0.36 and a 12-month high of $4.37. The firm has a market capitalization of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09. The stock’s fifty day simple moving average is $0.53 and its 200-day simple moving average is $0.77.
Analyst Ratings Changes
Separately, StockNews.com began coverage on Avinger in a research report on Monday, March 10th. They issued a “hold” rating on the stock.
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Featured Stories
- Five stocks we like better than Avinger
- Utilities Stocks Explained – How and Why to Invest in Utilities
- How to Build the Ultimate Everything ETF Portfolio
- Learn Technical Analysis Skills to Master the Stock Market
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.
